BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7557191)

  • 1. Photodynamic therapy: a new light on Barrett's esophagus.
    Lightdale CJ
    Gastrointest Endosc; 1995 Jul; 42(1):96-8. PubMed ID: 7557191
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer.
    Overholt BF; Panjehpour M
    Gastrointest Endosc; 1995 Jul; 42(1):64-70. PubMed ID: 7557181
    [No Abstract]   [Full Text] [Related]  

  • 3. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus.
    Laukka MA; Wang KK
    Gastrointest Endosc; 1995 Jul; 42(1):59-63. PubMed ID: 7557179
    [No Abstract]   [Full Text] [Related]  

  • 4. Photodynamic therapy for esophageal diseases: a clinical update.
    Prosst RL; Wolfsen HC; Gahlen J
    Endoscopy; 2003 Dec; 35(12):1059-68. PubMed ID: 14648421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of photodynamic therapy of Barrett's esophagus.
    Wang KK
    Gastrointest Endosc; 1999 Mar; 49(3 Pt 2):S20-3. PubMed ID: 10049443
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer.
    Overholt BF; Panjehpour M
    Semin Surg Oncol; 1995; 11(5):372-6. PubMed ID: 7569560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.
    Peters JH
    Gastrointest Endosc; 2010 Apr; 71(4):704-5. PubMed ID: 20363412
    [No Abstract]   [Full Text] [Related]  

  • 9. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus.
    Wolfsen HC
    Dig Dis; 2002; 20(1):5-17. PubMed ID: 12145415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
    Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of Barrett's esophagus.
    Wang KK
    Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):409-19. PubMed ID: 10899255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy in Barrett's esophagus.
    Overholt BF; Panjehpour M
    J Clin Laser Med Surg; 1996 Oct; 14(5):245-9. PubMed ID: 9612190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for Barrett's esophagus: does light still have a role?
    Wang KK; Lutzke L; Borkenhagen L; Westra W; Song MW; Prasad G; Buttar NS
    Endoscopy; 2008 Dec; 40(12):1021-5. PubMed ID: 19065486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus.
    Badreddine RJ; Prasad GA; Wang KK; Song LM; Buttar NS; Dunagan KT; Lutzke LS; Borkenhagen LS
    Gastrointest Endosc; 2010 Apr; 71(4):697-703. PubMed ID: 19959164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus.
    Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fléjou JF
    Gastrointest Endosc; 2004 Jun; 59(7):880-9. PubMed ID: 15173809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.
    Overholt BF; Panjehpour M; Haydek JM
    Gastrointest Endosc; 1999 Jan; 49(1):1-7. PubMed ID: 9869715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
    Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
    Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?
    Sharma P; Wani S; Rastogi A
    Gastrointest Endosc; 2007 Sep; 66(3):469-74. PubMed ID: 17725936
    [No Abstract]   [Full Text] [Related]  

  • 19. Photodynamic therapy.
    Davila ML
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
    Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C
    Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.